Semaglutide is making waves as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to produce more insulin and reducing glucagon https://haarisissk447967.jaiblogs.com/62677104/understanding-semaglutide-a-comprehensive-guide